PUBLISHER: Grand View Research | PRODUCT CODE: 1553629
PUBLISHER: Grand View Research | PRODUCT CODE: 1553629
The global intrathecal pumps market size is expected to reach at USD 513.3 million in 2030 and is projected to grow at a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for advanced intrathecal pumps for rapid delivery of medications into the spinal cord for faster pain relief is expected to boost the industry's growth during the forecast period.The advantages associated with intrathecal pumps are anticipated to augment the industry growth. Medications, such as opioids, when given through an intrathecal pain pump give superior pain relief as well as reduce side effects. Also, a small amount of medication is required in pain pumps as compared to the amount of medication taken in pill form, thereby increasing its preference among individuals.
The drug delivery therapy systems offer numerous benefits, such as effective pain relief, high patient satisfaction, reduced side effects compared to oral medication, and reduced use of pain medication. In addition, this treatment is effective and safe when used as directed and can be customized by varying the dosage as per need. Hence, rising demand for targeted drug delivery systems is expected to boost industry growth.The complications associated with the intrathecal catheter are creating hindrance in the industry growth. Occlusion, lacerations, and disconnection of the catheter cause a sudden cessation of intrathecal drug administration due to intrathecal catheter failure. Also, the majority of drug delivery device-related adverse events occurdue to the failure of the intrathecal catheter.